• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Shital Kamble, PhD

Latest:

Relationship Between Short-Acting β-Adrenergic Agonist Use and Healthcare Costs

Overuse of rescue medication among asthma patients is associated with increased exacerbations and higher total and asthma-related healthcare costs.


Donguk Kim, PhD

Latest:

Prevalence and Predictors of Hypoglycemia in South Korea

The prevalence and predictors of hypoglycemia in South Korean patients with type 2 diabetes were evaluated using a nationwide healthcare database.




Sarah Avery, PhD

Latest:

LIVESTRONG Fertility Training: Addressing the Needs of AYA Cancer Survivors

A discussion on the challenges of implementing standards for addressing fertility risks associated with cancer and its treatment and describes an interactive training for healthcare providers to help them overcome challenges to implementation.




Mark Bounthavong, PharmD, MPH

Latest:

New Start Versus Continuing Users on Aripiprazole: Implications for Policy

New starts on aripiprazole were less adherent than continuing users. Prescriptions for 90-day supplies should be reserved for patients who have established effectiveness and tolerance.







Miriam K. Hassan, BPharm, PhD

Latest:

Impact of Bipolar Disorder in Employed Populations

This systematic review examines the impact of bipolar disorder on employee attendance and functioning at work, along with the associated economic burden to US employers.


Kimberly Jinnett, PhD

Latest:

Breaking Barriers: Partnerships to Improve Diabetic Eye Health in Alabama

This article reviews barriers to diabetic eye health across Alabama and highlights a partnership with Genentech and the American Diabetes Association to address this issue.




Lindsay Andon, MSPH

Latest:

Association of Care Management Intensity With Healthcare Utilization in an All-Condition Care Management Program

Higher intensity of care management in an all-condition program addressing care coordination and care barriers was associated with increased healthcare utilization among Medicaid and Medicare patients.


Michael Donlin, MSN, ACNP-BC, FHM

Latest:

An Early Warning Tool for Predicting at Admission the Discharge Disposition of a Hospitalized Patient

We developed an early warning discharge disposition prediction tool to facilitate discharge planning and coordination, potentially reducing length of hospital stay and improving patient experience.



Zachary E. Myers

Latest:

Physician ePortfolio: The Missing Piece for Linking Performance With Improvement

Clinical data should contribute to practice-based learning and improvement, resulting in improved patient care as well as meeting increasingly rigorous physician accountability requirements.


Jamie Beach, RN

Latest:

False Activation of the Cardiac Catheterization Laboratory for Primary PCI

Between 2005 and 2011, rates of cardiac catheterization laboratory false activation doubled while mean door-to-balloon times for primary PCI declined.



Abigail Felix, BA

Latest:

Complying With State and Federal Regulations on Essential Drug Benefits: Implementing the Affordable Care Act

Essential health benefits form a cornerstone of the Affordable Care Act. Our study shows that health plans in California and Massachusetts are not fully compliant with state and federal regulations on essential drug benefits.


Denise A. Tyler, PhD

Latest:

Medicare Advantage Control of Postacute Costs: Perspectives From Stakeholders

This qualitative study examines the methods that Medicare Advantage plans use to control or reduce postacute spending and their associated unintended consequences.


Kun Li, MS

Latest:

Trends in Viral Hepatitis Cost-Effectiveness Studies

Regardless of the cause of bias, more awareness and scrutiny are needed when utilizing cost-effectiveness studies for healthcare decision making.




Sammy Saab, MD

Latest:

Treating Medicaid Patients With Hepatitis C: Clinical and Economic Impact

Hepatitis C virus treatment is often restricted in Medicaid patients. This analysis evaluates the clinical and cost impacts of treating all Medicaid patients versus the current status quo.


© 2024 MJH Life Sciences
AJMC®
All rights reserved.